Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Esther N. Katende"'
Autor:
Jonathan Nguyen, Jamie K Teer, Liang Wang, Anders Berglund, Fengshen Kuo, Jad Chahoud, Jasreman Dhillon, Youngchul Kim, Ali Hajiran, James J Mulé, Andrew Chang, Nicholas H Chakiryan, Gregory J Kimmel, Carlos Moran-Segura, Daryoush Saeed-Vafa, Esther N Katende, Neale Lopez-Blanco, Phillip Rappold, Philippe E Spiess, Michelle Fournier, Daniel Jeong, Abraham Ari Hakimi, Philipp M Altrock, Brandon J Manley
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 4 (2023)
Introduction In clear cell renal cell carcinoma (ccRCC), tumor-associated macrophage (TAM) induction of CD8+T cells into a terminally exhausted state has been implicated as a major mechanism of immunotherapy resistance, but a deeper biological unders
Externí odkaz:
https://doaj.org/article/2881fd9f660e47b2a1d040258d55687f
Autor:
Philipp M. Altrock, Brandon J. Manley, George Blanck, Esther N. Katende, Juan F. Arturo, Seyed Shayan A. Falasiri, Jasreman Dhillon, Erin M. Siegel, Michelle Fournier, James J. Mulé, Anders Berglund, Jamie K. Teer, Youngchul Kim, Boris I. Chobrutskiy, Nicholas H. Chakiryan, Meghan C. Ferrall-Fairbanks
Immune-modulating systemic therapies are often used to treat advanced cancer such as metastatic clear cell renal cell carcinoma (ccRCC). Used alone, sequence-based biomarkers neither accurately capture patient dynamics nor the tumor immune microenvir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d540b3511a9e533cde12d885f6ed3a63
https://doi.org/10.1158/0008-5472.c.6513682.v1
https://doi.org/10.1158/0008-5472.c.6513682.v1
Autor:
Philipp M. Altrock, Brandon J. Manley, George Blanck, Esther N. Katende, Juan F. Arturo, Seyed Shayan A. Falasiri, Jasreman Dhillon, Erin M. Siegel, Michelle Fournier, James J. Mulé, Anders Berglund, Jamie K. Teer, Youngchul Kim, Boris I. Chobrutskiy, Nicholas H. Chakiryan, Meghan C. Ferrall-Fairbanks
Supplementary Data from Quantification of T- and B-cell Immune Receptor Distribution Diversity Characterizes Immune Cell Infiltration and Lymphocyte Heterogeneity in Clear Cell Renal Cell Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f8eb4693dd42e01954e2fbfd2cfff7c
https://doi.org/10.1158/0008-5472.22430668
https://doi.org/10.1158/0008-5472.22430668
Autor:
Nicholas H Chakiryan, Youngchul Kim, Anders Berglund, Andrew Chang, Gregory J Kimmel, Ali Hajiran, Jonathan Nguyen, Carlos Moran-Segura, Daryoush Saeed-Vafa, Esther N Katende, Neale Lopez-Blanco, Jad Chahoud, Phillip Rappold, Philippe E Spiess, Michelle Fournier, Daniel Jeong, Liang Wang, Jamie K Teer, Jasreman Dhillon, Fengshen Kuo, Abraham Ari Hakimi, Philipp M Altrock, James J Mulé, Brandon J Manley
Publikováno v:
Journal for ImmunoTherapy of Cancer. 11:e006195
IntroductionIn clear cell renal cell carcinoma (ccRCC), tumor-associated macrophage (TAM) induction of CD8+T cells into a terminally exhausted state has been implicated as a major mechanism of immunotherapy resistance, but a deeper biological underst
Autor:
Meghan C. Ferrall-Fairbanks, Nicholas Chakiryan, Boris I. Chobrutskiy, Youngchul Kim, Jamie K. Teer, Anders Berglund, James J. Mulé, Michelle Fournier, Erin M. Siegel, Jasreman Dhillon, Seyed Shayan A. Falasiri, Juan F. Arturo, Esther N. Katende, George Blanck, Brandon J. Manley, Philipp M. Altrock
Publikováno v:
Cancer research : an official organ of the American Association for Cancer Research
Immune-modulating systemic therapies are often used to treat advanced cancer such as metastatic clear cell renal cell carcinoma (ccRCC). Used alone, sequence-based biomarkers neither accurately capture patient dynamics nor the tumor immune microenvir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a9db1e0b1a448fa7f58ff0ab9595b43
https://doi.org/10.1101/2021.06.15.21258987
https://doi.org/10.1101/2021.06.15.21258987
Autor:
Heather L Huelster, Elizabeth A. Green, Alex C. Soupir, Kyle M. Rose, Esther N. Katende, Shreyas U Naidu, Scott Michael Gilbert, Brandon J. Manley, Michael Adam Poch, Wade J. Sexton, Alice Yu, Philippe E. Spiess, Pan Du, Shidong Jia, Il-Jin Kim, Lu Tan, Liang Wang, Roger Li
Publikováno v:
Journal of Clinical Oncology. 40:4587-4587
4587 Background: Upper tract urothelial carcinoma (UTUC) is an aggressive cancer for which use of neoadjuvant chemotherapy (NAC) is limited by suboptimal clinical staging prior to nephroureterectomy. Detection of circulating tumor DNA (ctDNA) is asso
Autor:
Heather L. Huelster, Elizabeth A. Green, Alex C. Soupir, Esther N. Katende, Kyle M. Rose, Shreyas U. Naidu, Scott Michael Gilbert, Brandon J. Manley, Michael Adam Poch, Wade J. Sexton, Philippe E. Spiess, Alice Yu, Youngchul Kim, Pan Du, Shidong Jia, Il-Jin Kim, Lu Tan, Liang Wang, Roger Li
Publikováno v:
Journal of Clinical Oncology. 40:543-543
543 Background: Upper tract urothelial carcinoma (UTUC) is an aggressive cancer for which use of neoadjuvant chemotherapy (NAC) is limited by suboptimal clinical staging prior to nephroureterectomy. Detection of circulating tumor DNA (ctDNA) is assoc